Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis

• Published in: Neurological sciences 2023-02, Vol.44 (2), p.667-676
• Main Authors: Alonso, Ricardo, Eizaguirre, María Bárbara, López, Pablo, Silva, Berenice, Rojas, Juan Ignacio, Sinay, Vladimiro, Tkachuk, Verónica, Patrucco, Liliana, Carra, Adriana, Bruno, Diana, Pagani Cassara, Fátima, Fernández Liguori, Nora, Tavolini, Darío, Camerlingo, Sebastián, Garcea, Orlando, Galiani, Agostina, Mainella, Carolina, Barboza, Andrés, Luetic, Geraldine, Carnero Contentti, Edgar
• Format: Article
• Language: English
• Subjects: Adult; Clinical medicine; Consensus; COVID-19; Diagnosis; Humans; Medicine; Medicine & Public Health; Multiple sclerosis; Multiple Sclerosis - diagnosis; Multiple Sclerosis - epidemiology; Multiple Sclerosis - therapy; Neurology; Neuroradiology; Neurosciences; Neurosurgery; Original; Original Article; Pandemics; Patients; Psychiatry; Recurrence; Telemedicine
• ISSN: 1590-1874; 1590-3478
• DOI: 10.1007/s10072-022-06471-4

Background The use of telemedicine has quickly increased during of the COVID-19 pandemic. Given that unmet needs and barriers to multiple sclerosis (MS) care have been reported, telemedicine has become an interesting option to the care of these patients. The objective of these consensus recommendations was to elaborate a guideline for the management of people with MS using telemedicine in order to contribute to an effective and high-quality healthcare. Methods A panel of Argentinean neurologist’s experts in neuroimmunological diseases and dedicated to the diagnosis, management,and care of MS patients gathered virtually during 2021 and 2022 to conduct a consensus recommendation on the use of telemedicine in clinical practice in adult people with MS. To reach consensus, the methodology of “formal consensus RAND/UCLA Appropriateness method” was used. Results Recommendations were established based on relevant published evidence and expert opinion focusing on definitions, general characteristics and ethical standards, diagnosis of MS, follow-up (evaluation of disability and relapses of MS), identification and treatment of relapses, and finally disease-modifying treatments using telemedicine. Conclusion The recommendations of this consensus would provide a useful guide for the proper use of telemedicine for the assessment, follow-up, management, and treatment of people with MS. We suggest the use of these guidelines to all the Argentine neurologists committed to the care of people with MS.